# Amryt Pharmaceuticals, Inc. – FDA Inspection, Jan 23, 2020

Source: https://www.keypedia.com/records/fda_inspections/amryt-pharmaceuticals-inc/ea72e082-e7f6-4428-b809-fae7e3ab5b9f
Source feed: FDA_Inspections

> FDA inspection 1122448 of Amryt Pharmaceuticals, Inc., January 23, 2020. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122448
- Company Name: Amryt Pharmaceuticals, Inc.
- Inspection Date: 2020-01-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1180597 - 2022-09-14
- [FDA Inspection 947089 - 2015-07-16](https://www.keypedia.com/records/fda_inspections/amryt-pharmaceuticals-inc/bbd0d1a7-4a50-4861-b85c-b447fe5011c2)
- FDA Inspection 797858 - 2012-08-27

Company: https://www.keypedia.com/companies/amryt-pharmaceuticals-inc/bfdef8ed-47d6-408f-a59b-16c2f17d796a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
